These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6447546)

  • 1. In vitro alloreactivity of mouse bone marrow lymphocytes.
    Brankovan V; Rosse C
    Cell Immunol; 1980 Aug; 54(1):1-10. PubMed ID: 6447546
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergy between spleen cells and bone marrow cells in mixed lymphocyte culture-induced cytotoxicity. Requirement for macrophages in the induction of synergy.
    Maki T; Monaco AP
    Cell Immunol; 1980 Dec; 56(2):323-37. PubMed ID: 6451299
    [No Abstract]   [Full Text] [Related]  

  • 3. [HLA and lymphocyte physiology].
    Lebrun A
    Union Med Can; 1981 Apr; 110(4):303-12. PubMed ID: 6454297
    [No Abstract]   [Full Text] [Related]  

  • 4. Alloreactivity: an old puzzle revisited.
    Nagy ZA
    Scand J Immunol; 2012 May; 75(5):463-70. PubMed ID: 22229944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of soluble allo-MHC class I antigen in vivo suppresses IL-2 production by allo-reactive helper T cells.
    Geissler EK; Graeb C; Jauch KW; Scherer MN
    Transplant Proc; 1999; 31(1-2):742-3. PubMed ID: 10083316
    [No Abstract]   [Full Text] [Related]  

  • 6. The human Ia system.
    Winchester RJ; Kunkel HG
    Adv Immunol; 1979; 28():221-92. PubMed ID: 94505
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and characterization of human bone marrow lymphocyte subpopulations: evidence for the existence of an alloreactive immature T cell.
    Wulff JC; Held H; Mueller-Hermelink HK; Schlaak M
    Clin Exp Immunol; 1981 Jun; 44(3):485-90. PubMed ID: 6459896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the alloimmune response to minor histocompatibility antigens by in vivo MLR.
    Song HK; Noorchashm H; Lieu YK; Rostami S; Greeley SA; Barker CF; Naji A
    Transplant Proc; 1999; 31(1-2):836-7. PubMed ID: 10083363
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to isoantigens and mitogens in the cat: effects of cyclosporin A.
    Gregory CR; Taylor NJ; Willits NH; Theilen GH
    Am J Vet Res; 1987 Jan; 48(1):126-30. PubMed ID: 2950813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens.
    Muraoka S; Miller RG
    J Exp Med; 1980 Jul; 152(1):54-71. PubMed ID: 6447187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
    Hill GR; Teshima T; Rebel VI; Krijanovski OI; Cooke KR; Brinson YS; Ferrara JL
    J Immunol; 2000 Jan; 164(2):656-63. PubMed ID: 10623807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. The Journal of Experimental Medicine. 1973. 138: 1289-1304.
    Sachs DH; Cone JL
    J Immunol; 2011 Sep; 187(5):2045-60. PubMed ID: 21856943
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of immunity and oral tolerance to alloantigen by polymorphic class II major histocompatibility complex allopeptides in the rat.
    Sayegh MH; Khoury SJ; Hancock WW; Weiner HL; Carpenter CB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):357-8. PubMed ID: 8438333
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural killer cells and their possible relevance to transplantation biology.
    Herberman RB
    Transplantation; 1982 Jul; 34(1):1-7. PubMed ID: 6214877
    [No Abstract]   [Full Text] [Related]  

  • 15. Nature and significance of the human equivalent of the mouse H-2I region.
    Carpenter CB
    Adv Nephrol Necker Hosp; 1981; 10():241-64. PubMed ID: 6455909
    [No Abstract]   [Full Text] [Related]  

  • 16. Incorporation of murine MHC antigens into liposomes and their effect in the secondary mixed lymphocyte reaction.
    Curman B; Ostberg L; Peterson PA
    Nature; 1978 Apr; 272(5653):545-7. PubMed ID: 151232
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of blocking effect of chondroitin sulfate on lymphocyte-defined antigens.
    Toledo-Pereyra LH; Fox BA; Gordon DA; Jennings J
    Transplantation; 1979 Jun; 27(6):429-30. PubMed ID: 37621
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of responses of alloantigen primed lymphocytes in secondary MLC.
    Singal DP
    Transplant Proc; 1978 Dec; 10(4):771-4. PubMed ID: 153610
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1747-53. PubMed ID: 6452477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.